Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: chest pain major surgical or invasive procedure: endogastric duodenoscopy history of present illness: 74yo female initially presented to osh for having sscp x several days, with sob and doe. at the osh: cxr unremarkable, ct with ground glass opacities, resolved with lasix, echo 60-65%levf & mild pulm htn, thallium stress test with anterolateral reversible defects. she was sent to for elective cath. past medical history: spinal stenosis arthritis htn niddm hyperlipidemia s/p cholecystectomy social history: lives alone, former polaroid employee, no kids, no exercise, no smoking or drug use. rare etoh family history: mother died of dm at age 69, father died of mi at age 69. brothers with stents x2. physical exam: pe: vitals: 95.6 130/70 20 98%ra gen: obese female lying in bed in nad heent: nc/at, sclera anicteric, op clear neck: supple, no jvd cv: reg rate, s1 s2, systolic murmur loudest at lusb lung: ctab abd: soft, obese, nt/nd, +bs ext: trace edema, wwp. pertinent results: labs - 06:40am blood wbc-8.0 rbc-3.68* hgb-11.0* hct-32.3* mcv-88 mch-29.9 mchc-34.1 rdw-13.2 plt ct-244 10:47pm blood wbc-8.2 rbc-2.97* hgb-8.6* hct-26.8* mcv-90 mch-29.0 mchc-32.2 rdw-12.6 plt ct-268 03:45am blood wbc-8.8 rbc-3.57* hgb-10.4* hct-31.5* mcv-88 mch-29.1 mchc-33.0 rdw-13.3 plt ct-223 06:40am blood plt ct-244 06:40am blood glucose-108* urean-16 creat-0.8 na-136 k-3.9 cl-104 hco3-24 angap-12 03:45am blood calcium-8.6 phos-2.8 mg-1.9 ekg: brief hospital course: she was admitted to for cath. she tolerated the procedure well, stent placed with no complication (plavix, heparin given intra-procedurally), integrillin post cath. she was sent to floor for overnight observation. she developed emesis of 100 cc with clots, ngt placed with 400cc bright red blood that did not clear. gi called, pt transferred to micu for emergent scope. scope demonstrated clean duodenal bulb, oozing areas within antrum of stomach and adherent clot, no brisk bleed identified, epinephrine did not alleviate oozing. she was hemodynamically stable throughout episodes of hematemesis (pre emesis hct 28.2) and scope. she was started on protonix 40 mg . repeated egd on the next day showed some linear streaks of erythematous mucosa with no active bleeding noted in the antrum. anticoagulant including asa and plavix restarted. her hematocrit was stable for 48 hours post upper gi bleed. for her cad, metoprolol was titrated up to 25 mg , lisinopril was started and lipitor was increased to 80 mg daily. for her diabetes, actos was held on admission and was restarted on day of discharge. she was covered with riss. of note, patient was constipated, without bowel movements for 7 days. she was given an enema in the micu with no relief. on day of discharge she was given another fleet ns enema and lactulose and dulcolax. we ordered a kub to evaluate for obstruction, given the length of constipation. kub showed no dilated loops of bowel and no air fluid levels. because she looked well clinically we decided to discharge her. she will have vna and will watch for signs of bleeding and obstruction. medications on admission: atorvastatin 10 atenolol 50 amlodipine 10 velocoxib traglitazone (recently stopped) glyburide (recently stopped) discharge medications: 1. clopidogrel bisulfate 75 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 2. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* 3. miconazole nitrate 2 % powder sig: one (1) appl topical (2 times a day) as needed. disp:*90 g* refills:*0* 4. lisinopril 5 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 5. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 6. pioglitazone hcl 30 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 7. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed for constipation. disp:*60 capsule(s)* refills:*1* 8. aspirin ec 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po once a day. disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 9. lipitor 80 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 10. bisacodyl 5 mg tablet sig: one (1) tablet po at bedtime as needed for constipation for 3 days. disp:*6 tablet(s)* refills:*0* discharge disposition: home with service facility: discharge diagnosis: cororary artery disease s/p stent of lad upper gi bleed hypertention dmii hyperlipidemia discharge condition: good discharge instructions: please take all medications as prescribed please return to care for blood in you stool, dark black stools, blood in vomit, nausea, vomiting, lightheadedness, shortness of breath or chest pain please follow up with your pcp this week and have them guaic your stool. you will need to take plavix for at least 3 months please follow up with your cardiologist in months your baseline hematocrit is 32. if the results show less than 30, you must call your pcp. followup instructions: call your primary care doctor for a follow up within 1 week. , g. please follow up with a cardiologist in weeks, you can see dr. at , or dr. . please follow up with dr. (gi). you will need an endoscopy in 1 month. procedure: coronary arteriography using two catheters other endoscopy of small intestine injection or infusion of platelet inhibitor left heart cardiac catheterization endoscopic control of gastric or duodenal bleeding transfusion of packed cells insertion of drug-eluting coronary artery stent(s) diagnoses: coronary atherosclerosis of native coronary artery intermediate coronary syndrome unspecified essential hypertension morbid obesity unspecified gastritis and gastroduodenitis, with hemorrhage esophagitis, unspecified 

Answer: The patient is high likely exposed to